Drugs & Targets AnHeart, Foundation Medicine form collaboration focused on NSCLC diagnostic December 15, 2023Vol.49 No.46
Drugs & Targets Fuse Oncology, University of Michigan form radiation oncology collaboration December 15, 2023Vol.49 No.46
Drugs & Targets FDA grants Fast Track designation to Alpha1H for non-muscle invasive bladder cancer December 08, 2023Vol.49 No.45
Drugs & Targets FDA approves Xtandi for non-metastatic castration-sensitive prostate cancer with biochemical recurrence December 01, 2023Vol.49 No.44
Drugs & Targets FDA grants Breakthrough Therapy Designation to epcoritamab-bysp December 01, 2023Vol.49 No.44
Drugs & Targets FDA approves Keytruda + chemo for HER2-negative gastric or GEJ cancer November 17, 2023Vol.49 No.43
Drugs & Targets FDA approves Edison histotripsy device to treat liver tumors November 17, 2023Vol.49 No.43
